Avanos Medical AVNS Effect of exchange rate changes on cash, cash equivalents and restricted cash
Effect of exchange rate changes on cash, cash equivalents and restricted cash at other companies
Other financials
Where this comes from
Reported directly by Avanos Medical in its filing.
Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Avanos Medical's effect of exchange rate changes on cash, cash equivalents and restricted cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Avanos Medical's effect of exchange rate changes on cash, cash equivalents and restricted cash?
- Avanos Medical (AVNS) reported effect of exchange rate changes on cash, cash equivalents and restricted cash of -$1M in Q1 2026.
- How has Avanos Medical's effect of exchange rate changes on cash, cash equivalents and restricted cash changed year-over-year?
- Avanos Medical's effect of exchange rate changes on cash, cash equivalents and restricted cash decreased by 155.6% year-over-year, from $1.8M to -$1M.
- What does effect of exchange rate changes on cash, cash equivalents and restricted cash mean?
- Measures the impact of fluctuations in foreign currency exchange rates on the reported value of cash and cash equivalents held in non-functional currencies. It helps investors isolate operational cash changes from currency volatility.